| Towards an artificial intelligence framework for data-driven prediction of coronavirus clinical severity X Jiang, M Coffee, A Bari, J Wang, X Jiang, J Huang, J Shi, J Dai, J Cai, ... Computers, Materials & Continua 63 (1), 537-551, 2020 | 525* | 2020 |
| The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment MA Haendel, CG Chute, TD Bennett, DA Eichmann, J Guinney, WA Kibbe, ... Journal of the American Medical Informatics Association 28 (3), 427-443, 2021 | 399 | 2021 |
| Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future CT Bauch, JO Lloyd-Smith, MP Coffee, AP Galvani Epidemiology 16 (6), 791-801, 2005 | 374 | 2005 |
| Modelling the impact of migration on the HIV epidemic in South Africa M Coffee, MN Lurie, GP Garnett Aids 21 (3), 343-350, 2007 | 239 | 2007 |
| Patterns of movement and risk of HIV infection in rural Zimbabwe MP Coffee, GP Garnett, M Mlilo, HACM Voeten, S Chandiwana, ... The Journal of infectious diseases 191 (Supplement_1), S159-S167, 2005 | 164 | 2005 |
| In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice P Okunieff, M Mester, J Wang, T Maddox, X Gong, D Tang, M Coffee, ... Radiation research 150 (2), 204-211, 1998 | 130 | 1998 |
| Déjà vu: stimulating open drug discovery for SARS-CoV-2 S Ekins, M Mottin, PRPS Ramos, BKP Sousa, BJ Neves, DH Foil, KM Zorn, ... Drug discovery today 25 (5), 928-941, 2020 | 110 | 2020 |
| Open drug discovery for the Zika virus S Ekins, D Mietchen, M Coffee, TP Stratton, JS Freundlich, ... F1000Research 5, 2016 | 72 | 2016 |
| To explain or not to explain?—Artificial intelligence explainability in clinical decision support systems J Amann, D Vetter, SN Blomberg, HC Christensen, M Coffee, S Gerke, ... PLOS Digital Health 1 (2), e0000016, 2022 | 71 | 2022 |
| HIV and Schistosoma haematobium prevalences correlate in sub‐Saharan Africa ML Ndeffo Mbah, EM Poolman, PK Drain, MP Coffee, MJ van der Werf, ... Tropical medicine & international health 18 (10), 1174-1179, 2013 | 66 | 2013 |
| Prognostic indicators for Ebola patient survival SJ Crowe, MJ Maenner, S Kuah, BR Erickson, M Coffee, B Knust, J Klena, ... Emerging infectious diseases 22 (2), 217, 2016 | 64 | 2016 |
| A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus S Ekins, JS Freundlich, M Coffee F1000Research 3, 2014 | 62* | 2014 |
| Illustrating and homology modeling the proteins of the Zika virus S Ekins, J Liebler, BJ Neves, WG Lewis, M Coffee, R Bienstock, ... F1000Research 5, 2016 | 52 | 2016 |
| Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March … TD Filardo, MR Khan, N Krawczyk, H Galitzer, S Karmen-Tuohy, M Coffee, ... PloS one 15 (11), e0242760, 2020 | 50 | 2020 |
| Co-design of a trustworthy AI system in healthcare: deep learning based skin lesion classifier RV Zicari, S Ahmed, J Amann, SA Braun, J Brodersen, F Bruneault, ... Frontiers in Human Dynamics 3, 688152, 2021 | 37* | 2021 |
| On assessing trustworthy AI in healthcare. Machine learning as a supportive tool to recognize cardiac arrest in emergency calls RV Zicari, J Brusseau, SN Blomberg, HC Christensen, M Coffee, ... Frontiers in Human Dynamics 3, 673104, 2021 | 28 | 2021 |
| FDA approved drugs as potential Ebola treatments S Ekins, M Coffee F1000Research 4, 2015 | 21* | 2015 |
| Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms MC Anasse Bari, Matthias Heymann, Ryan J Cohen, Robin Zhao, Levente Szabo ... Clinical Infectious Diseases, 2022 | 19 | 2022 |
| Finding small molecules for the ‘next Ebola’ S Ekins, C Southan, M Coffee F1000Research 4, 2015 | 19* | 2015 |
| Assessing trustworthy AI in times of COVID-19: deep learning for predicting a multiregional score conveying the degree of lung compromise in COVID-19 patients H Allahabadi, J Amann, I Balot, A Beretta, C Binkley, J Bozenhard, ... IEEE Transactions on Technology and Society 3 (4), 272-289, 2022 | 16 | 2022 |
sean ekinsCollaborations Pharmaceuticals, Inc.Verifierad e-postadress på collaborationspharma.com
